Positive correlation between chronic hyperglycemia and serum fetuin-A levels in middle-aged and elderly Chinese

Journal of Diabetes

Volumn 4, Issue 4, 2012, Pages 351-358

  Liu, Yu ^a   Xu, Min ^a,b   Xu, Yu ^a   Li, Mian ^a   Wang, Tiange ^a   Chen, Yuhong ^a,b   Bi, Yufang ^a,b  

^a BEIJING HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Fetuin A; HbA1c; Hyperglycemia

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; FETUIN A; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DRUG TARGETING; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; ALPHA-2-HS-GLYCOPROTEIN; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED;

EID: 84870308389     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12000     Document Type: Article

References (27)

1. Yang G, Kong L, Zhao W et al. Emergence of chronic non-communicable diseases in China. Lancet. 2008; 72: 1697-705.
2. Leahy JL, Cooper HE, Deal DA, Weir GC. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J Clin Invest. 1986; 77: 908-15.
3. Fujimoto Y, Torres TP, Donahue EP, Shiota M. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes. 2006; 55: 2479-90.
4. Kim JK, Zisman A, Fillmore JJ et al. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest. 2001; 108: 153-60.
5. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem. 2004; 279: 42 351-4.
6. Veerababu G, Tang J, Hoffman RT. Over expression of glutamine: Fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. Diabetes. 2000; 49: 2070-8.
7. Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004; 53(Suppl.): 119-24.
8. Cruz AB Jr, Amatuzio DS, Grande F, Hay LJ. Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ Res. 1961; 9: 39-43.
9. Liu HY, Cao SY, Hong T, Han J, Liu Z, Cao W. Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM). J Biol Chem. 2009; 284: 27 090-100.
10. Nakajima K, Yamauchi K, Shigematsu S et al. Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells. J Biol Chem. 2000; 275: 20 880-6.
11. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32: 1327-34.
12. Auberger P, Falquerho L, Contreres JO et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and antimitogenic activity. Cell. 1989; 58: 631-40.
13. Brix JM, Stingl H, Höllerl F, Schernthaner GH, Kopp HP, Schernthaner G. Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endorinol Metab. 2010; 95: 4877-81.
14. Li M, Xu M, Bi Y et al. Association between higher serum fetuin-A concentrations and abnormal albuminuria in middle-aged and elderly Chinese with normal glucose tolerance. Diabetes Care. 2010; 33: 2462-4.
15. Stefan N, Fritsche A, Weikert C et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008; 57: 2762-7.
16. Xu Y, Xu M, Bi Y et al. Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese. Atherosclerosis. 2011; 216: 180-6.
17. Takata H, Ikeda Y, Suehiro T et al. High glucose indcuces transactivation of the α2-HS glycoprotein gene through the ERK1/2 signaling pathway. J Atheroscler Thromb. 2009; 16: 448-56.
18. Ning G, Bi Y, Wang T et al. Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in Chinese adults: A cross-sectional analysis. Ann Intern Med. 2011; 155: 368-74.
19. IPAQ Research Committee. Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ). Available from: http://www.ipaq.ki.se/scoring.pdf (accessed 1 January 2010).
20. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003; 139: 137-47.
21. Kantartzis K, Machann J, Schick F, Fritsche A, Häring HU, Stefan N. The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia. 2010; 53: 882-9.
22. Mori K, Emoto M, Araki T et al. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism. 2008; 57: 1248-52.
23. Kaushik SV, Plaisance EP, Kim T et al. Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. Diabetes Metab Res Rev. 2009; 25: 427-34.
24. Mathews ST, Singh GP, Ranalletta M et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. 2002; 51: 2450-8.
25. Lin X, Braymer HD, Bray GA, York DA. Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. Life Sci. 1998; 63: 145-53.
26. Stefan N, Hennige AM, Staiger H et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006; 29: 853-7.
27. Dasgupta S, Bhattacharya S, Biswas A et al.NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochem J. 2010; 429: 451-62.